Low-Dose Oral Minoxidil as Treatment for COVID-19-Related Telogen Effluvium: Results From a Retrospective Series of 69 Patients
Our findings suggest that LDOM is a safe and effective therapy for patients with CATE.
Authors
- David Saceda‐Corralo (ORCID: https://orcid.org/0000-0001-6315-5462)
- Estefania Boland‐Rodríguez (ORCID: https://orcid.org/0000-0002-5077-9468)
- Juan Garza (ORCID: https://orcid.org/0000-0001-6287-0042)
- César Daniel Villarreal‐Villarreal (ORCID: https://orcid.org/0000-0003-2432-2517)
- Daniela Mares-Custodio (ORCID: https://orcid.org/0000-0002-0432-1149)
- Daniel Asz‐Sigall (ORCID: https://orcid.org/0000-0003-1848-5686)
Institutions
- Universidad de Alcalá (ES)
- Instituto Cajal (ES)
- Hospital General Dr. Manuel Gea Gonzalez (MX)
- Tecnológico de Monterrey (MX)
Publication Details
- Journal
- Actas Dermo-Sifiliográficas
- Published
- 2025-12-18
- DOI
- https://doi.org/10.1016/j.ad.2025.104569
- Primary Topic
- Hair Growth and Disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00